Please select the option that best describes you:
Topics:
Rheumatology • Spondyloarthritis • General Rheumatology • Ankylosing spondylitis • JAK Inhibitors
How would you approach management of a patient with ankylosing spondylitis who was doing well on tofacitinib, but experienced a STEMI while on therapy?
The patient has a history of sacroillitis, uveitis, severe inflammatory oligoarthritis, +HLAB27, and had previously failed two TNF inhibitors, was doing well on tofacitinib.
The emphasis on the rationale for the two anti-TNF...